Clinica Fabia Mater Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01221844
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Clinica Fabia Mater, Via Olevano Romano 25, Rome (Italy)

Active Ingredients

Drugs in Phase 4 Trials (2)

ferrous sulfate (1 trial)

lactoferrin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Deficiency Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2